Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE: 300705)
Health Care · Pharmaceuticals · CN
CN¥11.44
+4.76% today · -40.7% 1Y
Hunan Jiudian Pharmaceutical Co., Ltd. (SZSE: 300705) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $841.00M and employs 2,298 people.
Over the last twelve months the share price has lost 40.7%, trading between 9.26 and 20.66.
Tweenvest scores Hunan Jiudian Pharmaceutical Co., Ltd. across four factors: quality 69/100, value 77/100, growth 85/100, dividend 30/100. Its strongest factor is growth.
300705 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $841.00M
- Revenue (TTM)
- $424.83M
- P/E
- 14.96
- EPS
- 0.81
- Dividend yield
- 3.66%
- Beta (5Y)
- -0.14
- 52-week high
- CN¥20.66
- 52-week low
- CN¥9.26
- Avg volume (3M)
- —
- Shares outstanding
- 494.11M
- Employees
- 2,298
- Next earnings
- —
About Hunan Jiudian Pharmaceutical Co., Ltd.
Hunan Jiudian Pharmaceutical Co., Ltd. is a Chinese pharmaceutical enterprise that spans the entire value chain from drug discovery and development to manufacturing and commercialization. The company's extensive product line includes medications for treating allergies, infections, and inflammatory conditions, as well as analgesics and gynecological remedies. Their offerings further extend to products for digestive health, both Western chemical drugs and traditional Chinese patent medicines, medical equipment, and Active Pharmaceutical Ingredients (APIs). Additionally, Hunan Jiudian provides contract manufacturing services for various pharmaceutical formulations, such as tablets, capsules, granules, and oral liquid preparations like solutions and syrups. The company is headquartered in Changsha, China.
- ISIN
- CNE1000034Z6
- Founded
- 2001
- Listed since
- Oct 10, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.